Clinical Trial Update: Prevalence of Genetic Polymorphisms in Genes Coding for Tamoxifen Metabolising Enzymes

View source ↗

Summary

This clinical trial update reports the prevalence of genetic polymorphisms in genes coding for enzymes that metabolize tamoxifen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Vlaamse Vereniging voor Obstetrie en Gynaecologie | Conditions: Breast Neoplasms | Status: COMPLETED